Skip to content
buyModerate

Lynx1 Capital Management LP bought $206k of PASG

owner at Passage BIO, Inc.. 50,055 shares at an average of $4.12, traded Jun 25, 2026, filed Jun 29, 2026.

Conviction score
45
Value
$206k
50,055 shares
Holdings after
673,759
+8% from before
From 52-week low
+6%
low $4.08, close $4.33
From 52-week high
-78%
high $19.85, as of Jun 25, 2026

Score components

  • Role
    10% owner
    +12
  • Trade size
    $206k at market
    +12
  • Relative to holdings
    Holdings up 8%
    +3
  • Price context
    6% above the 52-week low; 78% below the 52-week high
    +18
  • Cluster
    No other insider buying within 14 days
    0
  • Repeat buying
    First buy in 90 days
    0
  • Track record
    Median 6-month excess return +1% over 12 past buys
    +5
  • Outside holder
    A 10% owner who is not an officer or director
    -5

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

PASGOct 12, 2026 · close 4.55
Since filing Jun 29, 2026: -6.2%SPY +5.3% · excess -11.5%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0000902664-26-002945, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 25, 2026POpen-market purchase
Common stock, $0.0001 par value per share ("Common Stock")indirect: See footnote
+50,055$4.12$206k673,759Jun 29, 2026

Related signals

Other insiders at Passage BIO, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
31Weak
PASGsell 2
Passage BIO, Inc.
Kathleen Borthwick
CFO
$38k
2,062 shares
-28%
36Weak
PASGsell 2
Passage BIO, Inc.
William Chou
PRESIDENT AND CEO
$75k
4,076 shares
-38%
35Weak
PASGbuy
Passage BIO, Inc.
Lynx1 Capital Management LP
owner
$224k
32,008 shares
+5%
52Moderate
PASGbuy
Passage BIO, Inc.
Lynx1 Capital Management LP
owner
$734k
128,848 shares
+28%
24Weak
PASGsell
Passage BIO, Inc.
Orbimed Advisors LLC
owner
$197k
583,657 shares
-9%
21Weak
PASGsell
Passage BIO, Inc.
Orbimed Advisors LLC
owner
$79k
235,572 shares
-3%
19Weak
PASGsell
Passage BIO, Inc.
Orbimed Advisors LLC
owner
$50k
149,054 shares
-2%
7Weak
PASGsell
Passage BIO, Inc.
Kathleen Borthwick
CFO
$1,686
3,183 shares
-7%
25Weak
PASGbuy
Passage BIO, Inc.
Lynx1 Capital Management LP
owner
$241k
373,645 shares
+4%
23Weak
PASGsell
Passage BIO, Inc.
Orbimed Advisors LLC
owner
$138k
230,321 shares
-3%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.